NCT03195205View on ClinicalTrials.gov

Identification to Elimination in HCV-Infected Individuals

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

3,051

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

April 20, 2020

Study Completion Date

April 20, 2020

Conditions

Hepatitis C

Interventions

DIAGNOSTIC_TEST

OraQuick HCV Rapid Antibody Test

HCV Screening

Trial Locations (1)

15801

TruCare Internal Medicine & Infectious Diseases, DuBois

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

TruCare Internal Medicine & Infectious Disease

OTHER